| Tag | Content |
|---|
EnhancerAtlas ID | HS133-18012 |
Organism | Homo sapiens |
Tissue/cell | melanoma |
Coordinate | chr2:208147220-208148650 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxd3 | MA0041.1 | chr2:208148459-208148471 | GTTTGTTTGTTT | + | 6.32 | | Foxd3 | MA0041.1 | chr2:208148463-208148475 | GTTTGTTTGTTT | + | 6.32 | | Foxd3 | MA0041.1 | chr2:208148467-208148479 | GTTTGTTTGTTT | + | 6.32 | | IRF1 | MA0050.2 | chr2:208147921-208147942 | ATAGAGAAAAAGAAAGTGAAA | - | 7.12 | | IRF1 | MA0050.2 | chr2:208147927-208147948 | AAAAAGAAAGTGAAAGGGAGA | - | 8.17 | | SPIC | MA0687.1 | chr2:208148130-208148144 | AAAATGGGGAAGAA | + | 6.04 | | ZNF263 | MA0528.1 | chr2:208147949-208147970 | AAAGGTGGAGGGAGAGGAAAG | + | 6.16 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_59922 | chr2:208103819-208151310 | Ly4 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 208147712 | 208147800 | | chr2 | 208147800 | 208148458 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I207283 | chr2 | 208147725 | 208148890 |
|
Enhancer Sequence | AGTGGAAATT AGATCCAGAA AAAGCTCTCA TATCATGGCC TTCATTCATA ATGCAATTGA 60
AAAATTGTGT TTGGGGAAAT TCTGGAAACA AATGCCCCCA AAACTCATCA ATGCCTTTCT 120
ATCATCATTT AGTACTAGGA GGGGGGTGCC AAGAAGATGT CTACTGAATT GCTAAAGCAA 180
TAAATTGAGG AGATAATCTT TTTCATGGTT GGTATGCTCA GGGGGAATAG GTCCAGCAGA 240
TAAAATGATA ACTAGATTTA GTTGACAATT TGCTTTGAGT AAAATGTCGA GCTTGTAAAT 300
AATTTTAAAA TAGCCTGTCA TTCAATTGTG GTGTGTCCTT TAAGAAATTT TAATCGATGG 360
AAAACACATT TCTCAAACAC AGCTTCTAAC CCCTGTGAAA CCAGCTATTG GTTTAAACAA 420
AAAGCTGTGA CACAATCAGA TCTGTGTGTG CAGTAGCTTA CTAAGGAGAG TGAATTGAAC 480
TACAACCCCA GAATTTCATA TTATAACAAT ATTCTGCAAC CTAAGAATTA GCTATTGAGA 540
TGACATGTGA TGTGGAAACA CACAACTTGT TCAGCCCTTT TTGCTCAAGG GCACTGAGAA 600
GCTGAGGTTT CCATCCACTC ATCAGAAACA ATCAACATAC ACATAAACTT TTGGCTGCAA 660
ATGGATTGTC TGTTTGGTAT CTTTGCCAAA AGCTCAGCAT TATAGAGAAA AAGAAAGTGA 720
AAGGGAGAGA AAGGTGGAGG GAGAGGAAAG ATATAGCAAC TGTCTGAAAT TAGGGTCTAG 780
TGTCACCTTG AGAAGATGAA CTCAAGAATA AAAATTCTAC TACAGAATTT GGGGGTGGGG 840
GAATCTCTCC TCACTCCCAC AACTATCAGT AATCTAAGCT AAAATCCCTT TCTACAGTGA 900
CATCCATGTC AAAATGGGGA AGAATAGTGA TCATTCTAAA TGTAACATGA GCAATTTGTC 960
GCCTTTTCCA GGCCCACTGC TTCCCCACTG TGGGTGCTGC AGAGGCAGTG GCTTTTCTTC 1020
CTCTTTCCCC TCTTCAACCC TGCCCAAGGC TGCACTGCTG GGGCACACAG CCTGGTGGCC 1080
TCCTCTGACT AAGCTGTTAT TTTCCTGAAG AACTTTTTAT CAAAGGAAAC CAATCATTGT 1140
CCAGCCCCTG GTGTCAGGAG ATGCAGCAGC AAAACCCCAA GGGCAATAGA AAGCTCTGGT 1200
TTTTTTAGGT TGAAACTCCT GGAGAAGATG TCTTGGGTTG TTTGTTTGTT TGTTTGTTTC 1260
TTGCTTGGAT CTGGAGAACA TTCTCTCTCT TTTTTTTCAA CATTGACATG GATTATAAAG 1320
ATATCATCCC AAATTGCTAG CATGGCAAAT AAACCAATAC AATTAGAGAA TAAGGACACC 1380
TCCTGAGCAT TTAACTGAGG CTGGCTAGGT GTTTATTTTT AATGAATTGA 1430
|
